5th Fermentation-Enabled Alternative Protein Summit

Event description

Don’t miss the 5th Fermentation-Enabled Alternative Protein Summit in San Francisco, February 24-26 2025!

This year’s summit offers premium insights from industry leaders, investors, and policymakers, including GFI’s principal fermentation scientist, Adam Leman, Ph.D., who will chair a session on unlocking market growth and longevity by overcoming funding bottlenecks and working collaboratively. With sessions covering R&D breakthroughs, manufacturing innovations, and commercial pathways, this event connects you directly with strategic players driving the industry forward. View the 2025 Agenda here.

2025 Highlights Include:

• Fermentation & Ingredient Innovation Track: Technical excellence with Meli Bio, NovoNutrients, Circe Bioscience, and more, covering strain development, bioprocessing, and high-quality ingredient formulation
• Product Development & Commercialization Track: Proven go-to-market strategies and partnerships with Tomorrow Farms, Schreiber Foods, The Mushroom Meat Co, and more
• Capital Infrastructure Development Focus Day: Building sustainable protein manufacturing at scale, featuring insights from Onego Bio, Roquette, The Good Food Institute, and Synata Bio
• Key Plenary Sessions: Gain insights into the investment landscape and strategic partnerships with industry leaders including ADM, Superbrewed Food, and FTW Ventures

Join 170+ business executives, innovation and R&D decision-makers from leading CPGs and ingredient providers, investors, and late-stage technology enablers to unlock the potential of this growing market. Use code GFI10 for 10% off your registration!

Quick Links: Homepage | Event Guide | Register

Event location

Meet the speakers

Adam Leman, Ph.D.

PRINCIPAL SCIENTIST, FERMENTATION, GFI

Adam is a Principal Scientist, Fermentation at GFI and is focused on the development of biomass fermentation and precision fermentation biotechnology for food protein. He earned a B.S. in Molecular Genetics from the University of Rochester and a Ph.D. from Drexel University College of Medicine in Molecular Biology. Adam’s postdoctoral studies concentrated on fungal genetics and systems biology. During his time in biotech, Adam implemented gene expression analyses in microbial, agtech, and human health studies to better characterize these systems and offer a deeper understanding for strain development and process improvement.